ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
Drug intolerance | 08.06.01.013 | 0.031851% | | Not Available |
Psychotic disorder | 19.03.01.002 | 0.012741% | | |
Lymphocyte morphology abnormal | 13.01.06.015 | 0.012741% | | Not Available |
Renal impairment | 20.01.03.010 | 0.057332% | | Not Available |
Hepatic enzyme abnormal | 13.03.01.020 | 0.012741% | | Not Available |
Breath sounds abnormal | 13.15.01.008 | 0.012741% | | Not Available |
Liver injury | 12.01.02.003; 09.01.07.022 | 0.070073% | | Not Available |
Cholestatic liver injury | 09.01.07.016 | 0.019111% | | Not Available |
Nail atrophy | 23.02.05.010 | - | - | Not Available |
Acute kidney injury | 20.01.03.016 | 0.089184% | | |
Drug-induced liver injury | 12.03.01.044; 09.01.07.023 | 0.101370% | | Not Available |
Substance-induced psychotic disorder | 19.03.01.007; 12.03.01.053 | 0.050962% | | Not Available |
Drug reaction with eosinophilia and systemic symptoms | 23.03.05.005; 10.01.01.021 | 0.318514% | | Not Available |
Autoimmune haemolytic anaemia | 01.06.01.004; 10.04.01.005 | 0.003324% | | Not Available |
Immune thrombocytopenic purpura | 01.08.01.007; 10.04.01.008 | 0.012741% | | Not Available |
Liver function test increased | 13.03.01.044 | 0.031851% | | Not Available |
Dermatitis exfoliative generalised | 10.01.01.029; 23.03.07.002 | 0.012741% | | Not Available |
Hilar lymphadenopathy | 22.09.03.005; 01.09.01.023 | 0.012741% | | Not Available |
IgA nephropathy | 20.05.01.016; 10.02.01.063 | 0.019111% | | Not Available |
Kussmaul respiration | 14.01.01.004; 22.02.01.008 | 0.012741% | | Not Available |
Meningitis tuberculous | 11.04.01.012; 17.06.10.005 | 0.003324% | | Not Available |
Normal newborn | 18.08.06.001 | 0.012741% | | Not Available |
Renal glycosuria | 20.05.03.020 | 0.012741% | | Not Available |
Respiratory rate increased | 13.15.01.004 | 0.012741% | | Not Available |
Limb hypoplasia congenital | 15.11.07.025; 03.11.07.025 | 0.012741% | | Not Available |
Anti-neutrophil cytoplasmic antibody positive vasculitis | 10.02.02.023; 24.05.02.016 | 0.003324% | | Not Available |
Cell death | 14.11.02.005; 08.03.03.003 | 0.012741% | | Not Available |
Histology abnormal | 13.18.02.004 | 0.012741% | | Not Available |
Primary progressive multiple sclerosis | 17.16.01.005 | 0.012741% | | Not Available |
Extrapulmonary tuberculosis | 11.04.01.011 | 0.012741% | | Not Available |